# A Study to Predict Atrial Fibrillation (AF) Burden in Participants With PAF and PsAF Treated With the VARIPULSE™ PFA Catheter

Study · id `cardio:ct-nct07788989` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07788989](<https://clinicaltrials.gov/study/NCT07788989>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07788989

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 2300 participants.

## Technical summary

Registry record NCT07788989. Non-randomized; no masking; primary purpose treatment. Start 2027-04-14 (anticipated); primary completion 2029-10-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 2300 participants (planned count; ClinicalTrials.gov record NCT07788989, source copy `cardio:ctgov-nct07788989-2026-11-03`, retrieved 2026-11-18)
- Planned start: 2027-04-14 (anticipated) (ClinicalTrials.gov record NCT07788989, source copy `cardio:ctgov-nct07788989-2026-11-03`, retrieved 2026-11-18)
- Primary completion: 2029-10-31 (anticipated) (ClinicalTrials.gov record NCT07788989, source copy `cardio:ctgov-nct07788989-2026-11-03`, retrieved 2026-11-18)
- Completion: 2030-03-29 (anticipated) (ClinicalTrials.gov record NCT07788989, source copy `cardio:ctgov-nct07788989-2026-11-03`, retrieved 2026-11-18)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07788989-2026-11-03`, retrieved 2026-11-18)

## The registry's words

- Brief title: A Study to Predict Atrial Fibrillation (AF) Burden in Participants With PAF and PsAF Treated With the VARIPULSE™ PFA Catheter
- Acronym: SPECTRA-AF
- Condition: Atrial Fibrillation
- Intervention (Device): VARIPULSE Catheter System (PVI)
- Intervention (Device): VARIPULSE Catheter System (PVI and PWI)
- Lead sponsor: Biosense Webster, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Biosense Webster, Inc. (`cardio:org-biosense-webster-inc`)

## Provenance

Content hash: 4ea362099ed5bed4b0830e5cdd0034ce17a6f2512794c27b86114273a3f2d7dc
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
